INTRODUCTION
Forward flexion of the trunk is a typical symptom of Parkinson's disease (PD) and, indeed, was identified by James Parkinson when he first described the disease in 1817. 1 Camptocormia (as known as "bent spine syndrome") corresponds to extreme forward flexion of the thoracolumbar spine. The condition -whose name is derived from the Greek words kamptos ("to bend") and kormos ("trunk") -was first described by Earle in 1815 2 and by Brodie in 1837. 3 It is characterized by pronounced flexion of the trunk and limited extension in the erect position, together with reduced flexion in the supine position. In the most severe cases, patients are literally "doubled over", causing considerable discomfort and handicap.
The condition's principal organic aetiologies include affections of the central and peripheral nervous system (of which the most common are PD and amyotrophic lateral sclerosis) and vascular, lenticular lesions. 4 Other rarer aetiologies 5, 6 include muscle disorders (muscular dystrophies and myopathies, notably amyloid myopathy 7 ), an adverse effect of valproic acid 8 and rheumatological causes (such as spinal stenosis and vertebral infections). Psychiatric causes have also been described, with camptocormia resulting from a psychogenic conversion reaction. 9 Even though this deformation has long been known in PD, very few formal observations have been reported in the literature. Camptocormia in PD was first studied by Djaldetti et al., who considered it to be a rare type of dystonia or an extreme form of rigidity. 10 A form of myopathy limited to the trunk extensor muscles was subsequently discussed. 11, 12 However, such reports have been limited to very small samples and have suffered from incomplete exploration of the included patients. The goal of the present study was to i) provide a more comprehensive description of the characteristics of parkinsonian patients who develop camptocormia, ii) identify the features of parkinsonian camptocormia and iii) discuss various hypotheses for the pathogenesis of this condition.
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PATIENTS AND METHODS

Subjects
The inclusion criteria were PD according to the Gelb criteria 13 and a totally or partially reducible forward flexion, because of the frequency of the fixed rachis deviation in our population.
We excluded patients with a possible or probable multiple system atrophy according to the Gilman criteria, with another atypical parkinsonian syndrome, with isolated head drop syndrome and non- were recruited with the diagnosis of PD and the presence of severe, reducible, forward flexion of the thoracolumbar spine, giving a hypothetic prevalence of about 3% which required confirmation on a larger prospective epidemiological study.
Methods
Clinical Examination
The following information was collected: age, gender, past and current medical history; current treatment; dates of onset for PD symptoms and camptocormia; motor fluctuations; autonomic disorders; back pain; variations in trunk flexion during the day and as a function of PD treatment. All patients were evaluated by a neurologist (ACL or DD) using the Unified Parkinson's Disease Rating Scale (UPDRS) part III and axial scores and the Mini-Mental State Examination (MMS).
The patients were also evaluated by a physiotherapist (AB or VP) with respect to their postural disorders and to discuss whether or not the use of a corset was desirable. The following data were also gathered: the maximal joint extension (for hips, knees and ankles) and the strength of the paraspinal muscles. The SpinalMouse® electronic measuring device was used to provide geometric data on spine and hip tilt, since it has been designed to measure sagittal back shape and mobility. The 
Additional investigations
The vertebral axis was studied using cervical and thoracolumbar radiography. The thoracolumbar spinal muscles and the girdle muscles were studied with magnetic resonance imaging (MRI) by the same radiologist (AC) for all patients. Cranial MRI was also performed, notably in order to study the basal ganglia.
Electromyographic recording of the thoracolumbar spinal erector muscle was performed by the same neurophysiologist (JFH) for all patients.
Clinical biochemistry investigations included serum creatine kinase, C-reactive protein, sedimentation rate, phosphate and calcium, thyroid function and immunological (antinuclear antibodies) tests.
Accessory salivary gland biopsies were performed in order to screen for possible amyloid or inflammatory abnormalities. A muscle biopsy was performed on the erector spinal muscles when an abnormal MRI signal was observed.
RESULTS
Clinical characteristics of parkinsonian patients with camptocormia (Table 1)
Fifteen male and 8 female patients were studied. Six had a family history of PD, of which 3 included camptocormia. The patients' age was 68.6 patients who presented camptocormia 5 years or less after the onset of PD, 4 had an akinetic-rigid syndrome and 7 had tremor-associated syndrome. Of the 11 patients who developed camptocormia after more than 5 years of PD, 6 had an akinetic-rigid syndrome and 5 had tremor-associated syndrome. Four patients had developed axial akinetic-rigid syndrome in the year following disease onset.
The ON drug UPDRS part III score was 26.7 ± 10 out of 108 and the axial score was 10.6 ± 3.2 out of 24. The axial UPDRS/motor UPDRS ratio was 0.40. Thirteen patients suffered from freezing (57%). Fifteen patients (65%) had motor fluctuations which developed 7 ± 3.6 years after disease onset: 8 of these individuals (34 %) had mild to moderate peak-dose dyskinesia, without axial involvement and 4 (17 %) had limb dystonia without axial involvement. Twenty-two patients (96%) had significant autonomic symptoms: 7 had orthostatic hypotension and 15 suffered from urinary disorders.
Cognitive function was normal for 9 patients (the MMS score was 27.1 ± 2.4. Seven patients had mild cognitive impairment, with attention deficit and memory disorders. Six patients had dopaminergic psychosis and one individual suffered from dementia.
All 23 patients received dopaminergic treatment, with a L-dopa equivalent dose of 939± 516 mg per day (Table1): 6 received L-dopa only and 15 received L-dopa in combination with a dopamine agonist. Finally, two patients received a dopamine agonist only. In general, L-dopa treatment had been introduced 1.9 ± 2.2 years after the diagnosis of PD. It preceded appearance of camptocormia by 4 ± 4.3 years in 19 patients and was started 1 year after the appearance of camptocormia in 2 patients.
One patient underwent high-frequency, chronic, bilateral deep brain stimulation of the subthalamic nucleus 4 years after the appearance of camptocormia, without any impact on the condition itself. 
Characteristics of camptocormia (
The history of camptocormia was 4.6 ± 2.6 years. Eighteen patients developed forward flexion of the trunk over a period greater than a year. Four patients reported the rapid appearance of camptocormia in less than 1 year: in 2 of these cases, the appearance of the condition appeared to be linked to surgical treatment (abdominal and hip surgery, respectively). Finally, one patient reported the acute (overnight) appearance of trunk flexion. Camptocormia fluctuated with administration of dopaminergic treatment in 5 patients, with an improvement in all cases. In 14 patients, the extent of the stooped posture varied throughout the diurnal cycle and was aggravated by fatigue and stress.
There was no correlation between camptocormia duration and L-dopa treatment duration.
The range of trunk flexions determined clinically and using the Spinal Mouse® varied from 40° in milder cases to 90° in the most severe ones. In 8 of the 23 patients, the condition completely disappeared in the supine position. In the other 15 patients, the spine was prevented from completely extending passively or when in the supine position because of permanent spinal deformation and axial rotation. Camptocormia was associated with scoliosis in 14 patients and was pain-free in 5 patients.
Eighteen individuals described low back pain aggravated by sitting, standing and walking. The pain score on a visual analogue scale (where 0 and 10 corresponded to "no pain" and "maximal pain", respectively) was 3.7 ± 2.7.
All patients displayed the same clinical pattern of postural disorders, with anteversion of the pelvis (9 out of 15 patients), axial front hypertonia with fixed flexion of the hips (10 out of 15 patients), knees (all 15) and ankles (all 15) and, finally, paresis of the paraspinal muscles (all 15 ).
In Table 3 , the measurements made with the Spinal Mouse® for the 15 patients are presented and compared with those determined by spinal radiography: a high degree of inter-technique correlation was found for both thoracic kyphosis (r=0.884; p=0.001) and lumbar lordosis (r=0.892; p=0.001).
Twelve patients wore a corset: the 8 flexible leather corsets were well tolerated (and resulted in a decrease in back pain in 6 wearers) and a rigid corset was well tolerated in one of the two patients who chose this device. Neither of the 2 moulded, supportive seats was well tolerated. Cranial MRI showed abnormal signals for the basal ganglia in 3 patients: one displayed a small lacunar infarct in the left putamen and the two remaining individuals had a lacunar infarct in the head of the left and right caudate nucleus, respectively. We noted that the patients with rapid-onset camptocormia had normal cranial MRI results.
Electromyography
When investigated with thoracolumbar spinal erector muscle electromyography, all the patients with a motor unit reduction were found to be suffering from involution of the muscle fibres seen in the paraspinal muscle MRI. There were no other correlations. Surface electromyography of the left lumbar paraspinal muscles was performed for the patient with a vascular lesion in the putamen but no dystonia-related paradoxical activities were apparent.
Clinical biochemistry
There were no significant abnormalities for any of the laboratory tests.
Histology
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Muscle biopsy was performed in the 5 patients who displayed signal abnormalities on their thoracolumbar spine MRI. For patient n°17, the STIR sequence revealed hyper intensity of the bilateral spinal muscles from T12 to L5, increased signal intensity after gadolinium injection and a fatty involution. The corresponding muscle biopsy showed an inflammatory infiltrate, with a few rimmed vacuoles but no characteristic tubulofilamentous inclusions visible in electron microscopythus excluding inclusion-body myositis. Our diagnosis was focal, paravertebral myositis. For patient n°21, the STIR sequence showed a large fatty infiltration in the paraspinal muscles, with bilateral signal hyperintensities. The muscle biopsy showed type II fibre atrophy and no signs of myositis. For patient n°19, the STIR sequence revealed hyperintensity at the edge of the right paraspinal muscles, with an increase in signal intensity after gadolinium injection and mild fatty infiltration. The muscle biopsy showed only fibrosis and fatty infiltration. The biopsy for the last two patients with MRI signal abnormalities for the paravertebral muscles showed fibrosis and fatty infiltration.
DISCUSSION
Clinical characteristics of parkinsonian patients with camptocormia
Our parkinsonian population displaying camptocormia was relatively old (median age = 70 years old), with a long disease duration (11 years). The UPDRS axial subscore (10 out of 24) was high when compared to the overall UPDRS motor score (26 out of 108, with a ratio of 0.43 for the most extreme value), suggesting a predominance of axial involvement in PD with camptocormia. 10 Their patient population was quite similar to that of the present study, with a mean age of 66 years, mean disease duration of 13.1 years and freezing of gait and motor fluctuations in 50% (4 out of 8 patients). All Djaletti et al.'s patients had an akinetic-rigid syndrome of PD, but this was not confirmed in our larger sample. Moreover, in our population, dyskinesia never involved the axial part of the body and axial dystonia was never noted.
Features of parkinsonian camptocormia
Here, camptocormia appeared 5.8 ± 4 years after disease onset and was not related to the treatment duration. The extent of the bent posture varied over the course of the day, and improved with L-dopa treatment in only 24% of patients. Camptocormia was also characterised by the high prevalence of lumbar or thoracolumbar scoliosis (in 61% of patients, preventing complete, passive extension) and by mild-to-moderate low back pain in 77 % of the patients. In the population described by Djaletti et al., the time interval between PD onset and the appearance of a severely bent posture ranged from 0 to 14 years. However, these authors also reported i) a worsening of the patients' bent posture by fatigue and ii) the lack of a relationship between the onset of L-dopa therapy and appearance of camptocormia. 10 For the patients reported by Wunderlich et al. 11 and Schabitz et al., 12 parkinsonian camptocormia appeared after 4 to 15 years of PD and, once again, was not greatly modified by antiparkinsonian therapy.
Possible physiopathological mechanisms of parkinsonian camptocormia
There are few literature reports 10, 11, 14 of the focal, paraspinal myopathy reported here, suggesting that the condition is rare but possibly not fortuitous in parkinsonian camptocormia. We only found 5 patients with abnormal muscle signals potentially related to focal, paraspinal myopathy.
Paraspinal muscle MRI signal abnormalities require cautious interpretation and do not necessarily imply inflammatory myopathy -especially since our biopsies did not reveal any specific histological features. The presence of a few rimmed vacuoles is not specific for inclusion-body myositis and can indicate a non-specific myositic process or muscle injury resulting from neuropathy.
11/20 A.-C. LEPOUTRE A combination of camptocormia and PD can also suggest mitochondrial disease involving the paraspinal muscles, 12 since mitochondrial DNA mutations have been considered as a physiopathological mechanism in PD. 24 Parkinsonian camptocormia could also be related to synecleinopathy, since Lewy bodies have been described in an advanced form of PD outside the central nervous system (CNS), in the neuronal cell body of the paravertebral sympathetic plexus.
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However, in PD, the spreading of mitochondriopathy and synucleopathy from the CNS to the muscle afferent neurons or paravertebral muscles has never been described.
Furthermore, another hypothesis for explaining parkinsonian camptocormia is dystonia of the trunk with excessive activation of the abdominal wall muscles. 10, 19, 20 Six of our 23 patients had familial antecedents of PD (including 3 with camptocormia) and a mutation in the parkin gene has been described with severe trunk dystonia (mimicking camptocormia). 21 However, all our patients were elderly and lacked familial antecedents of early-onset Parkinsonism and had no axial dystonia.
Moreover, the dystonia hypothesis cannot explain the resistance-free, passive reduction of camptocormia in the supine position.
Most of our patients had radiological signs of spondyloarthrotic changes, including lumbar or thoracolumbar scoliosis which might be a potential risk factor for developing camptocormia. 10 In PD, scoliosis might be secondary to postural imbalance, favoured by asymmetrical axial muscle tone 15, 16 Back pain could result from vertebral degeneration, as well as from paraspinal muscle hypertonia. 17 Parkinsonian camptocormia could be the consequence of axial rigidity of the flexion muscles, with a weakness of the erector spinal muscles -possibly due to dysfunction of the basal ganglia controlling the reticulospinal pathway. The reticulospinal's main projections are located in the axial muscles and controls dynamic and static posture: its dysfunction could also cause freezing and autonomic disturbances, 18 which were highly prevalent in our population. Camptocormia could be due to an imbalance between excessive central motor drive to the ventral and dorsal trunk musculatures (leading to excessive activation of the abdominal wall muscles) and reduced motor drive to the paraspinal muscles (which would favour secondary muscle atrophy and injury). 12 Indeed, we found 12/20 A.-C. LEPOUTRE that the most frequent MRI abnormality was a fatty involution in the paraspinal muscle region. Lack of use of the erector muscles (due to an extreme form of rigidity of the spinal flexion muscles) could induce this type of fatty involution. Subsequently, vertebral deformations could appear and might, in some patients, induce spinal nerve injuries via direct compression or stretching of the back branch, which in turn could increase muscle involution. 22, 23 The rare cases of focal myopathy could therefore stem from a mechanical pathogenesis with posture impairment, as proposed by Serratrice et al. 5 and
by Wunderlich et al. 11 Early physical therapy may be indicated in order to minimize the complications of this condition. 
